2.3(top 20%)
impact factor
7.9K(top 2%)
papers
183.2K(top 2%)
citations
131(top 5%)
h-index
2.4(top 20%)
impact factor
9.3K
all documents
189.9K
doc citations
188(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical UseJournal of Clinical Pharmacology20051,110
2A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsJournal of Clinical Pharmacology1984749
3The Anticholinergic Drug Scale as a Measure of Drug-Related Anticholinergic Burden: Associations With Serum Anticholinergic ActivityJournal of Clinical Pharmacology2006521
4Pharmacokinetics and Bioavailability of Quercetin Glycosides in HumansJournal of Clinical Pharmacology2001510
5A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of FundamentalsJournal of Clinical Pharmacology2002492
6DHEA and DHEA-S: A ReviewJournal of Clinical Pharmacology1999451
7Global Burden of Disease (GBD) for Hepatitis CJournal of Clinical Pharmacology2004429
8Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)Journal of Clinical Pharmacology2010423
9Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell HypothesisJournal of Clinical Pharmacology2005411
10Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy VolunteersJournal of Clinical Pharmacology2010392
11Cannabidiol: An Overview of Some Pharmacological AspectsJournal of Clinical Pharmacology2002385
12Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in HumansJournal of Clinical Pharmacology2010345
13New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance ProcessJournal of Clinical Pharmacology2008333
14Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone MetastasesJournal of Clinical Pharmacology2002329
15Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled TrialJournal of Clinical Pharmacology2000328
16Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to DrugsJournal of Clinical Pharmacology2007328
17Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaJournal of Clinical Pharmacology1996321
18Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic TargetJournal of Clinical Pharmacology1998315
19Origin and Uses ofPrimum Non Nocere-Above All, Do No Harm!Journal of Clinical Pharmacology2005311
20Dose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in HumansJournal of Clinical Pharmacology1997309
21Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59-7939) in Healthy SubjectsJournal of Clinical Pharmacology2007303
22Stability and Performance of a Population Pharmacokinetic ModelJournal of Clinical Pharmacology1997302
23Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic HemostasisJournal of Clinical Pharmacology1995287
24Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationJournal of Clinical Pharmacology1996285
25Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult SubjectsJournal of Clinical Pharmacology2002283
26Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled StudyJournal of Clinical Pharmacology1993278
27Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and ClopidogrelJournal of Clinical Pharmacology2008274
28Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsJournal of Clinical Pharmacology2001261
29Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy VolunteersJournal of Clinical Pharmacology2000261
30Cardiovascular System Effects of MarijuanaJournal of Clinical Pharmacology2002260
31Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction ApproachesJournal of Clinical Pharmacology2009260
32Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionJournal of Clinical Pharmacology1991256
33Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip ReplacementJournal of Clinical Pharmacology2005256
34Efficacy of Antidepressants as Analgesics: A ReviewJournal of Clinical Pharmacology2012254
35Hemodynamic Response to the Upright PostureJournal of Clinical Pharmacology1994253
36Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous SystemJournal of Clinical Pharmacology2001236
37Microbial Biofilms: Their Development and Significance for Medical Device-Related InfectionsJournal of Clinical Pharmacology1999232
38Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirJournal of Clinical Pharmacology1998228
39The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA PerspectiveJournal of Clinical Pharmacology2003228
40Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test AbnormalitiesJournal of Clinical Pharmacology2006228
41Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on HemodialysisJournal of Clinical Pharmacology2007224
42Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysisJournal of Clinical Pharmacology2016224
43Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteersJournal of Clinical Pharmacology2000221
44Effect of Food, an Antacid, and the H2Antagonist Ranitidine on the Absorption of BAY 59-7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy SubjectsJournal of Clinical Pharmacology2006220
45Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal FunctionJournal of Clinical Pharmacology2003219
46Safety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single- and Multiple-Dose Administration to Healthy Male and Female Adult VolunteersJournal of Clinical Pharmacology2007218
47Analgesic Effect of Delta‐9‐TetrahydrocannabinolJournal of Clinical Pharmacology1975216
48Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and TriazolamJournal of Clinical Pharmacology1999216
49Hypnotic and Antiepileptic Effects of CannabidiolJournal of Clinical Pharmacology1981214
50Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory ReviewJournal of Clinical Pharmacology2008206